A spectrum of contributions of type 2 diabetes and related metabolic characteristics to dementia.

A spectrum of contributions of type 2 diabetes and related metabolic characteristics to dementia.
复制标题

2 型糖尿病和相关代谢特征对痴呆的一系列影响。

DOI:
10.1016/j.euroneuro.2014.11.009
复制
发表时间:
2014
期刊:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
影响因子:
--
通讯作者:
SchnaiderBeeri,Michal
SchnaiderBeeri,Michal
中科院分区:
--
文献类型:
--
作者:
Ravona-Springer,Ramit;SchnaiderBeeri,Michal

文献摘要

相似文献

近年来流行病学、临床和临床前研究的结果表明,代谢因素在一般脑部疾病中的作用(De Felice 和 Ferreira,2014 年;Gorelick 等人,2011 年),特别是在阿尔茨海默病(AD)中(De Felice 和 Ferreira,2014 年;de la Monte 和 Tong,2014 年)。 2 型糖尿病 (T2D) 和糖尿病前期状态,例如非糖尿病受试者的胰岛素抵抗(Craft 等,2013)、血糖控制不良(Ma 等,2014;Ravona-Springer 等,2014)(Enzinger 等,2005)和肥胖(Emmerzaal 等,2014),会影响大脑结构和功能并参与其中在导致神经变性的神经病理学途径中。鉴于目前批准的治疗 AD 药物的疗效处于临界点(Tan 等人,2014 年),大量临床试验未能证明其他治疗该疾病的药物的疗效,以及医疗干预措施(American Diabetes,2010 年)和生活方式干预措施(Hays 等人,2008 年)在改善或预防 T2D 其他非脑相关并发症方面相对较好的疗效,这些发现提出了这样的可能性:干预可能对大脑产生有益的影响。
Findings from epidemiological, clinical and preclinical studies in recent years point to the role of metabolic factors in brain disease in general (De Felice and Ferreira, 2014; Gorelick et al., 2011), and particularly in Alzheimer’s disease (AD)(De Felice and Ferreira, 2014; de la Monte and Tong, 2014). Type 2 diabetes (T2D) and pre-diabetic states—such as insulin resistance (Craft et al., 2013), poor glycemic control (Ma et al., 2014; Ravona-Springer et al., 2014) in non-diabetic subjects (Enzinger et al., 2005), and obesity (Emmerzaal et al., 2014)—affect brain structure and function and are involved in the neuropathological pathways leading to neurodegeneration. In light of the borderline efficacy of currently approved medications for the treatment of AD (Tan et al., 2014), the failure of numerous clinical trials to prove efficacy of other medications developed for treatment of the disease, and the relatively good efficacy of medical (American Diabetes, 2010) and life-style (Hays et al., 2008) interventions in ameliorating or preventing other, non-brain-related complications of T2D, these findings raise the possibility that such interventions may have a beneficial effect on the brain.